<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T04:31:03Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/29086" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/29086</identifier><datestamp>2026-09-24T05:15:28Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Didar, Tohid</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Najm, Lubna</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biomedical Engineering</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2023-10-20T18:44:51Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2023-10-20T18:44:51Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2023</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/29086</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/20994</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Early-onset diagnostics, or the detection of disease before clinical symptoms arise, has&#xd;
gained traction for its potential to improve patient quality of life and health outcomes.&#xd;
Biosensors, found in point-of-care (POC) devices, facilitate early-onset diagnostics and&#xd;
disease monitoring by addressing the limitations of current diagnostics strategies, which&#xd;
include timeliness, cost-effectiveness, and accessibility. Biosensors often incorporate&#xd;
microarrays within their design to allow for the detection of disease-associated&#xd;
biomolecules, known as biomarkers. Microarrays are composed of capture biomolecules,&#xd;
such as monoclonal antibodies, that are immobilized through either contact or non-contact&#xd;
printing techniques. In the following thesis, we investigated microarray designs within&#xd;
novel biosensing platforms for diagnostic and disease monitoring applications. First, we&#xd;
highlighted the advantages and challenges of implementing different types of biosensors,&#xd;
detection methods, and biomolecule immobilization strategies. Additionally, we proposed&#xd;
a novel 3D microarray incorporating hydrogels composed purely of crosslinked bovine&#xd;
serum albumin (BSA) proteins decorated with capture antibodies (CAbs). Utilizing&#xd;
industry-standard inkjet printing, we developed and optimized a two-step fabrication&#xd;
protocol, by which BSA proteins and CAbs are printed first, followed by the crosslinking&#xd;
agent, 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide (EDC). Characterization of the&#xd;
unique three-dimensional (3D) microstructure and hydrogel parameters and conducting&#xd;
comparisons with standard two-dimensional (2D) microdots, showed that increasing&#xd;
biosensor surface area led to a 3X increase in signal amplification. The limits of detection&#xd;
(LODs) for cytokine biomarkers were 0.3pg/mL for interleukin-6 (IL-6) and 1pg/mL for tumor necrosis factor receptor I (TNF RI), which were highly sensitive compared to&#xd;
reported LODs from literature. Alongside the investigation of novel printing protocols,&#xd;
proof-of-concepts for multiplex detection and distinguishing clinical patient samples from&#xd;
healthy donors were also presented. Overall, this thesis demonstrated the fabrication and&#xd;
optimization of microarray development shows promise in improving current biosensor&#xd;
designs, allowing for enhanced early-onset disease detection and monitoring.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Applied Science (MASc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biosensors</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Microarrays</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Bioprinting Techniques</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Multiplex Detection</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Diagnostics</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Investigating and Optimizing Biomarker Microarrays to Enhance Biosensing Capabilities for Diagnostics</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>